The post BlackRock’s Bitcoin ETF Becomes Company’s Most Profitable Product appeared on BitcoinEthereumNews.com. BlackRock’s Bitcoin exchange-traded fund has surprised everyone by becoming the world’s largest asset manager’s most profitable product line. This achievement is remarkable given that BlackRock manages over 1,400 ETFs globally and controls more than $13.4 trillion in total assets. Cristiano Castro, BlackRock’s director of business development in Brazil, made this announcement at the Blockchain Conference in São Paulo. Castro called the development “a big surprise” and admitted they were optimistic when launching but “didn’t expect this scale.” Record-Breaking Performance Numbers The iShares Bitcoin Trust (IBIT) launched in January 2024 and quickly broke industry records. The fund reached $70 billion in assets in just 341 days, making it the fastest-growing ETF in history. Currently, IBIT holds $70.7 billion in net assets and has generated an estimated $245 million in annual fees by October 2025. These numbers are impressive when compared to BlackRock’s flagship products. By July 2025, the Bitcoin ETF was generating more revenue than BlackRock’s S&P 500 tracker, despite being much smaller in total assets. This happens because IBIT charges a 0.25% annual fee, while traditional index funds charge much lower fees. Source: @BitcoinArchive The fund attracted over $52 billion in net inflows during its first year, far outpacing all other ETFs launched in the last decade. IBIT now holds more than 3% of Bitcoin’s total supply, making it a significant player in the cryptocurrency market. Major Institutional Investors Join In Harvard University made headlines by investing heavily in BlackRock’s Bitcoin ETF. The prestigious university’s endowment fund held $443 million worth of IBIT shares as of September 30, 2025, representing over 20% of its U.S. public equity holdings. Harvard’s investment is particularly noteworthy because university endowments typically avoid ETFs, preferring private equity and real estate investments instead. The university tripled its Bitcoin ETF position in the third quarter of 2025,… The post BlackRock’s Bitcoin ETF Becomes Company’s Most Profitable Product appeared on BitcoinEthereumNews.com. BlackRock’s Bitcoin exchange-traded fund has surprised everyone by becoming the world’s largest asset manager’s most profitable product line. This achievement is remarkable given that BlackRock manages over 1,400 ETFs globally and controls more than $13.4 trillion in total assets. Cristiano Castro, BlackRock’s director of business development in Brazil, made this announcement at the Blockchain Conference in São Paulo. Castro called the development “a big surprise” and admitted they were optimistic when launching but “didn’t expect this scale.” Record-Breaking Performance Numbers The iShares Bitcoin Trust (IBIT) launched in January 2024 and quickly broke industry records. The fund reached $70 billion in assets in just 341 days, making it the fastest-growing ETF in history. Currently, IBIT holds $70.7 billion in net assets and has generated an estimated $245 million in annual fees by October 2025. These numbers are impressive when compared to BlackRock’s flagship products. By July 2025, the Bitcoin ETF was generating more revenue than BlackRock’s S&P 500 tracker, despite being much smaller in total assets. This happens because IBIT charges a 0.25% annual fee, while traditional index funds charge much lower fees. Source: @BitcoinArchive The fund attracted over $52 billion in net inflows during its first year, far outpacing all other ETFs launched in the last decade. IBIT now holds more than 3% of Bitcoin’s total supply, making it a significant player in the cryptocurrency market. Major Institutional Investors Join In Harvard University made headlines by investing heavily in BlackRock’s Bitcoin ETF. The prestigious university’s endowment fund held $443 million worth of IBIT shares as of September 30, 2025, representing over 20% of its U.S. public equity holdings. Harvard’s investment is particularly noteworthy because university endowments typically avoid ETFs, preferring private equity and real estate investments instead. The university tripled its Bitcoin ETF position in the third quarter of 2025,…

BlackRock’s Bitcoin ETF Becomes Company’s Most Profitable Product

BlackRock’s Bitcoin exchange-traded fund has surprised everyone by becoming the world’s largest asset manager’s most profitable product line.

This achievement is remarkable given that BlackRock manages over 1,400 ETFs globally and controls more than $13.4 trillion in total assets.

Cristiano Castro, BlackRock’s director of business development in Brazil, made this announcement at the Blockchain Conference in São Paulo. Castro called the development “a big surprise” and admitted they were optimistic when launching but “didn’t expect this scale.”

Record-Breaking Performance Numbers

The iShares Bitcoin Trust (IBIT) launched in January 2024 and quickly broke industry records. The fund reached $70 billion in assets in just 341 days, making it the fastest-growing ETF in history. Currently, IBIT holds $70.7 billion in net assets and has generated an estimated $245 million in annual fees by October 2025.

These numbers are impressive when compared to BlackRock’s flagship products. By July 2025, the Bitcoin ETF was generating more revenue than BlackRock’s S&P 500 tracker, despite being much smaller in total assets. This happens because IBIT charges a 0.25% annual fee, while traditional index funds charge much lower fees.

Source: @BitcoinArchive

The fund attracted over $52 billion in net inflows during its first year, far outpacing all other ETFs launched in the last decade. IBIT now holds more than 3% of Bitcoin’s total supply, making it a significant player in the cryptocurrency market.

Major Institutional Investors Join In

Harvard University made headlines by investing heavily in BlackRock’s Bitcoin ETF. The prestigious university’s endowment fund held $443 million worth of IBIT shares as of September 30, 2025, representing over 20% of its U.S. public equity holdings.

Harvard’s investment is particularly noteworthy because university endowments typically avoid ETFs, preferring private equity and real estate investments instead. The university tripled its Bitcoin ETF position in the third quarter of 2025, showing growing confidence in the product.

Even BlackRock itself is betting on its Bitcoin ETF’s success. The company’s Strategic Income Opportunities Portfolio increased its IBIT stake by 14%, demonstrating internal confidence in the fund’s future growth.

Revenue Comparison With Traditional Products

BlackRock’s Bitcoin ETF success shows how fee structures can create profitable products even with smaller asset bases. While the company’s S&P 500 ETF manages about $624 billion in assets, it charges only 0.03% in fees. IBIT’s higher 0.25% fee rate on its growing asset base generates more total revenue.

This pricing power reflects the unique costs of managing cryptocurrency products, including custody, insurance, and regulatory requirements. Investors have accepted these higher fees for convenient, regulated access to Bitcoin exposure.

The success also highlights how specialized ETF products can command premium pricing in new market categories, unlike traditional index funds that compete mainly on low costs.

Recent Market Challenges and Recovery

November 2025 brought significant challenges for IBIT, with the fund experiencing $2.34 billion in outflows during the month – the largest monthly outflows since the fund’s January 2024 launch. The largest single-day withdrawals occurred on November 18 ($523 million) and November 14 ($463 million), coinciding with Bitcoin price volatility.

However, Castro emphasized that these outflows represent normal market behavior for liquid ETF products. He explained that when assets experience price compression, retail investors typically adjust their positions, especially in volatile instruments like cryptocurrency funds.

The fund has since recovered as Bitcoin climbed back above $90,000. Investors now sit on cumulative gains of approximately $3.2 billion, reversing earlier losses when profits had dropped to just $630 million.

Market Impact and Trading Activity

IBIT’s influence extends beyond just asset gathering. In late November 2025, Bitcoin ETFs recorded a massive $40 billion in trading volume during a single week, with IBIT accounting for nearly 70% of the total at $27.79 billion.

The fund’s options market has also gained significant traction. IBIT options, introduced in November 2024, now rank among the most actively traded ETF-based derivatives, averaging $1.7 billion in daily notional volume.

This trading activity demonstrates how IBIT has become a central hub for Bitcoin-related investment activity, providing both institutional and retail investors with regulated access to cryptocurrency exposure.

The Bigger Picture

BlackRock’s Bitcoin ETF success represents a major shift in how traditional finance views cryptocurrency. The world’s largest asset manager legitimizing Bitcoin through a regulated product has encouraged other institutions to follow suit.

The combined U.S. and Brazil Bitcoin ETF assets under the IBIT nameplate came very close to $100 billion at their peak, according to Castro. This milestone shows how quickly institutional demand for Bitcoin exposure has grown when provided through familiar investment vehicles.

Bottom Line: Digital Gold Rush Pays Off

BlackRock’s Bitcoin ETF has proven that cryptocurrency products can become highly profitable for traditional asset managers willing to embrace new technologies. The fund’s success in generating more revenue than established products demonstrates the potential for innovation in the ETF industry, even for companies with decades of experience managing traditional investments.

Source: https://bravenewcoin.com/insights/blackrocks-bitcoin-etf-becomes-companys-most-profitable-product

Market Opportunity
Moonveil Logo
Moonveil Price(MORE)
$0.00221
$0.00221$0.00221
-5.10%
USD
Moonveil (MORE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23